Valuation: OrthoPediatrics Corp.

Market Cap 670M 574M 537M 491M 922M 64.08B 934M 6.34B 2.47B 32.19B 2.51B 2.46B 106B P/E 2026 *
-21x
P/E 2027 * -31.5x
Enterprise Value 670M 574M 537M 491M 922M 64.08B 934M 6.34B 2.47B 32.19B 2.51B 2.46B 106B EV / Sales 2026 *
2.51x
EV / Sales 2027 * 2.24x
Free-Float
67.68%
Yield 2026 *
-
Yield 2027 * -
1 day-2.21%
1 week+3.43%
Current month+27.04%
1 month+31.61%
3 months+39.18%
6 months+51.24%
Current year+44.43%
1 week 24.32
Extreme 24.325
26.74
1 month 18.1
Extreme 18.1
26.74
Current year 14.42
Extreme 14.42
26.74
1 year 14.42
Extreme 14.42
26.74
3 years 14.42
Extreme 14.42
38.99
5 years 14.42
Extreme 14.42
73.91
10 years 14
Extreme 14.0001
73.91
Manager TitleAgeSince
Chief Executive Officer 47 2021-06-02
Director of Finance/CFO 58 2015-01-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 47 2021-11-02
Chairman 75 2021-06-02
Director/Board Member 70 2010-12-31
Date Insider Type Main position Quantity % Market Cap.
12/29/25 Don

Chief Executive Officer

1,600 0.0064%
11/10/25 Free

Director

4,345 0.0173%
11/10/25 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-2.21%+3.43%+33.94%-32.85% 670M
+0.53%-2.88%-14.39%+19.26% 126B
-0.37%-2.42%-22.78%0.00% 12.26B
0.00%+0.20%+105.91%+153.52% 10.9B
-4.90%-8.39%-51.16%-69.73% 4.14B
-0.43%-1.43%-24.43%+49.81% 2.69B
+1.78%+9.21%-31.94%-71.42% 1.8B
-1.13%-0.43%-23.87%-13.53% 1.66B
-3.68%-3.53%-36.09%-38.01% 1.61B
Average -1.16%-0.16%-7.20%-0.33% 18.01B
Weighted average by Cap. +0.22%-2.50%-8.35%+22.94%

Financials

2026 *2027 *
Net sales 267M 229M 214M 196M 368M 25.54B 372M 2.53B 986M 12.83B 1B 981M 42.44B 299M 256M 240M 219M 411M 28.59B 417M 2.83B 1.1B 14.36B 1.12B 1.1B 47.5B
Net income -28.77M -24.65M -23.06M -21.11M -39.62M -2.75B -40.14M -272M -106M -1.38B -108M -106M -4.57B -18.48M -15.83M -14.81M -13.56M -25.45M -1.77B -25.78M -175M -68.25M -888M -69.39M -67.88M -2.94B
Net Debt - -
Logo OrthoPediatrics Corp.
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Employees
602
Date Price Change Volume
26-08-21 US$25.65 -2.21% 364,624
26-08-20 US$26.23 -1.02% 259,617
26-08-19 US$26.50 +3.92% 378,005
26-08-18 US$25.50 +3.24% 206,276
26-08-17 US$24.70 -0.40% 177,326
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
25.65USD
Average target price
27.22USD
Spread / Average Target
+6.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KIDS Stock